Researchers at the University of Manitoba are developing a groundbreaking dual-mode imaging technology designed to enhance breast cancer detection. This innovative system uniquely couples ultrasound with microwave imaging, a world-first in simultaneous application.
Professor Joe LoVetri, leading the project, stated that the technology aims to complement existing screening methods, likely serving as a secondary scan after initial mammograms to confirm the presence of cancer. His team has successfully addressed fundamental scientific challenges and is now progressing towards product development.
Winnipeg-based medical imaging company Taumedis is partnering to transform the prototype into a clinically acceptable product. Taumedis CEO Henry Floreal explained their role in making the technology comfortable and acceptable for research and clinical use. The first human study is planned for later this year, pending regulatory and ethics approvals. If successful, Taumedis will pursue FDA commercial licensing, sales, and marketing. This advancement promises a safer, more comfortable imaging alternative that avoids ionizing radiation, potentially reducing wait times and benefiting both clinicians and patients.